Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Peptidomic characterization and amino acid availability after intake of casein vs. a casein hydrolysate in a pig model

  • Jiménez-Barrios, Pablo
  • Sánchez Rivera, Laura
  • Martínez-Maqueda, D.
  • Le Gouar, Yann
  • Dupont, Didier
  • Miralles, Beatriz
  • Recio, Isidra
This article belongs to the Special Issue Role of Food Digestion and Digestive System in the Nutritional, Functional and Health Properties of Food Bioactives., It is known that casein hydrolysis accelerates gastrointestinal transit in comparison to intact casein, although the effect of the protein hydrolysis on the composition of the digests is not fully understood. The aim of this work is to characterize, at the peptidome level, duodenal digests from pigs, as a model of human digestion, fed with micellar casein and a previously described casein hydrolysate. In addition, in parallel experiments, plasma amino acid levels were quantified. A slower transit of nitrogen to the duodenum was found when the animals received micellar casein. Duodenal digests from casein contained a wider range of peptide sizes and a higher number of peptides above five amino acids long in comparison with the digests from the hydrolysate. The peptide profile was markedly different, and although β-casomorphin-7 precursors were also found in hydrolysate samples, other opioid sequences were more abundant in the casein digests. Within the same substrate, the evolution of the peptide pattern at different time points showed minimal changes, suggesting that the protein degradation rate relies more on the gastrointestinal location than on digestion time. Higher plasma concentrations of methionine, valine, lysine and amino acid metabolites were found in animals fed with the hydrolysate at short times (<200 min). The duodenal peptide profiles were evaluated with discriminant analysis tools specific for peptidomics to identify sequence differences between both substrates that can be used for future human physiological and metabolic studies., This work has received financial support from grants PID2019-107663RB-I00 and PDC2022-133489-I00 funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CCK and GLP-1 response on enteroendocrine cells of semi-dynamic digests of hydrolyzed and intact casein

  • Vivanco-Maroto, Santiaga María
  • Gallo, Verónica
  • Miralles, Beatriz
  • Recio, Isidra
A semi-dynamic gastrointestinal device was employed to explore the link between protein structure and metabolic response upon digestion for two different substrates, a casein hydrolysate and the precursor micellar casein. As expected, casein formed a firm coagulum that remained until the end of the gastric phase while the hydrolysate did not develop any visible aggregate. Each gastric emptying point was subjected to a static intestinal phase where the peptide and amino acid composition changed drastically from that found during the gastric phase. Gastrointestinal digests from the hydrolysate were characterized by a high abundancy of resistant peptides and free amino acids. Although all gastric and intestinal digests from both substrates induced the secretion of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) in STC-1 cells, GLP-1 levels were maximum in response to gastrointestinal digests from the hydrolysate. The enrichment of protein ingredients with gastric-resistant peptides by enzymatic hydrolysis is proposed as strategy to deliver protein stimuli to the distal gastrointestinal tract to control food intake or type 2 diabetes., This work has received financial support from projects PID2019-107663RB-I00 and PDC2022-133489-I00, both, funded by MCIN/AEI/10.13039/501100011033 from the Spanish Ministry of Science and Innovation (MICINN), and the latter counting with funds from EU “NextGeneration EU”/PRTR. SMVM is the recipient of contract (PIE 202070E069) from CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A lysozyme-derived peptide induces GLP-1 secretion in mouse jejunal organoids and modulates glycemia in rats

  • Vivanco-Maroto, Santiaga María
  • López de las Hazas, María-Carmen
  • Herradón, Esperanza
  • Girón, Rocío
  • Miralles, Beatriz
  • Paniagua, Nancy
  • López-Miranda, Visitación
  • Dávalos, Alberto
  • Recio, Isidra
Protein digestion products promote the release of incretins, such as GLP-1, which regulate glucose homeostasis. Our previous studies demonstrated that the egg white peptide fraction stimulates GLP-1 secretion in STC-1 cells. Here, the GLP-1 secretion induced by the lysozyme-derived peptide 123WIRGCRL129 and six alanine-substituted analogues was evaluated in mouse jejunal organoids, alongside egg white digest and the amino acid phenylalanine (Phe). Phe induced a faster GLP-1 response, but the peptide 123WIRGCRL129 elicited a similar GLP-1 response, although tested at a 20-fold lower concentration. The GLP-1 release in organoids elicited by the peptide was 57.8 ± 5 pM, while Phe reached 43.7 ± 1 pM at 60 min. In STC-1 cells, the peptide induced 667.7 ± 24.2 pM of GLP-1 compared to 416.6 ± 40.1 pM induced by Phe. Results obtained in STC-1 suggested the involvement of ERK- and AMPK-mediated pathways in the GLP-1 secretion induced by the peptide. Oral glucose tolerance tests in Wistar rats after oral administration of 123WIRGCRL129 showed a reduction in glucose levels, while no changes were observed in the group receiving the amino acid mixture at equimolar concentration. These findings suggest the potential therapeutic application of some food peptides against type 2 diabetes., This work has received financial support from projects PID2023-1465420B-I00 and PDC2022-133489-I00, both funded by MCIN/AEI/10.13039/501100011033 from the Spanish Ministry of Science and Innovation (MICINN), and the latter counting with funds from the EU “NextGeneration EU”/PRTR. S.M.V.-M. is the recipient of a contract (PIE 202070E069) from CSIC. M.-C.L.d.l.H. is a recipient of a Juan de la Cierva Grant (IJC2020-044353-/MCIN/AEI/10.13039/501100011033/EU/PRTR). CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain., Peer reviewed